naltrexone has been researched along with n-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corley, G; Rawls, SM | 1 |
Hiramoto, K; Yamate, Y; Yokoyama, S | 1 |
2 other study(ies) available for naltrexone and n-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide
Article | Year |
---|---|
Opioid, cannabinoid CB1 and NOP receptors do not mediate APAP-induced hypothermia in rats.
Topics: Acetaminophen; Aminoquinolines; Animals; Benzamides; Body Temperature; Hypothermia, Induced; Male; Naltrexone; Nociceptin Receptor; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Opioid; Rimonabant | 2009 |
Ultraviolet A eye irradiation ameliorates colon carcinoma induced by azoxymethane and dextran sodium sulfate through β-endorphin and methionine-enkephalin.
Topics: Aminoquinolines; Animals; Azoxymethane; Benzamides; beta-Endorphin; Colon; Colonic Neoplasms; Dextran Sulfate; Enkephalin, Methionine; Eye; Female; Interleukin-6; Ki-67 Antigen; Mice, Inbred ICR; Naltrexone; Receptors, Opioid; Receptors, Opioid, mu; Tumor Necrosis Factor-alpha; Ultraviolet Rays | 2017 |